October 14, 2019
1 min read
Save
ORION-11
Issue: October 2019
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Evaluation of the efficacy, safety and tolerability of a subcutaneous injection of inclisiran (The Medicines Company).